The progression of dysplasia and ESCC from native squamous epithelium is characterized by genomic alterations, such as driver mutations in tumor suppressor genes NOTCH1 and TP53, oncogene NFE2L2, activation of NRF2 pathway and WNT-β-catenin pathway [14]. Here, NFE2L2 is linked to esophageal squamous cell carcinoma.